For years, scientists have been trying to come up with a better way to protect people from mycobacterium tuberculosis, a disease caused by Mycobacterium tuberculosis (Mtb) infection. Dr. Jordi Torrelles, a professorRead More…
The Inovio Pharmaceuticals recently announced that a second patient with human papillomavirus (HPV) head and neck cancer has achieved sustained complete remission in the first phase of the trial after INO-3112 (nowRead More…
Sanofi has announced that the FDA has approved Vaxelis, a full-liquid ready-to-use hexavalent combination vaccine for infants from 6 weeks old to 4 years old (before the 5th birthday). The vaccine isRead More…
In a recent study published in Science Advances, scientists from the Scripps Research Institute overcame technical hurdles to develop a new HIV vaccine candidate that stimulates the body to produce a powerfulRead More…
Sanofi, a French pharmaceutical giant, recently announced that the US Food and Drug Administration (FDA) has accepted the dengue vaccine Dengvaxia’s Biologics License Application (BLA) and granted priority review. The vaccine isRead More…